glp-1 gastric intestinal obstruction lawsuit in west virginia Wegovy® Ozempic® Lawsuit | July 2026

Widespread access to GLP-1 therapies could generate significant benefits to society and produce huge savings for Medicare, Schaeffer research shows

Patients were considered to be on treatment for the period during which prescriptions were refilled before the estimated end date of the most recent prescription, including a 90-day grace period, i.e

Gastroparesis is characterized by delayed gastric emptying, with symptoms such as nausea, vomiting and abdominal pain, in the absence of mechanical obstruction

This study is based on data from the Clinical Practice Research Datalink obtained under license from the UK Medicines and Healthcare products Regulatory Agency

Gain insights for a healthier you.

Daily nutrition routines focused on balance and consistency